Josh Mailman - NorCal CarciNET Community

基本信息

浏览量：5

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 25 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Symptom Management for Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline

Kimberly Perez,Jaydira Del Rivero, Erin B Kennedy,Sandip Basu,Aman Chauhan, Heidi M Connolly, Arvind N Dasari,Alexandra Gangi,Callisia N Clarke, Julie Hallet, James R Howe, Erin Grady,Jana Ivanidze, Erik S Mittra,Sarah B White, Nitya P Raj,Namrata Vijayvergia,Mark A Lewis,Jennifer A Chan, Pamela L Kunz,Josh Mailman, Junaid Arshad,Heloisa P Soares,Simron Singh, Chandrika Chandrasekharan,Michael C Soulen,Eva Tiensuu Janson, Thorvardur R Halfdanarson, Jonathan R Strosberg,Emily K Bergsland

JCO oncology practicepp.OP2500133-OP2500133, (2025)

引用0浏览0WOS引用

Researcher Experience and Comfort with Telemedicine and Remote Patient Monitoring in Cancer Treatment Trials

Morgan R. L. Lichtenstein,Laura A. Levit,Caroline Schenkel,Kelsey Kirkwood,Lola A. Fashoyin-Aje,Suanna S. Bruinooge,Michael J. Kelley,Josh A. Mailman,Allison Magnuson, Daniel P. Mirda,Divya Natesan,Dawn L. Hershman

ONCOLOGIST（2024）

引用2浏览0WOS引用

Methodology of the SORENTO Clinical Trial: a Prospective, Randomised, Active-Controlled Phase 3 Trial Assessing the Efficacy and Safety of High Exposure Octreotide Subcutaneous Depot (CAM2029) in Patients with GEP-NET

Singh, Simron,Ferone, Diego,Capdevila, Jaume,Chan, Jennifer Ang,de Herder, Wouter W.,Halperin, Daniel,Mailman, Josh,Hellström, Lisa, Liedman, Hanna,Svedberg, Agneta,Tiberg, Fredrik

TRIALSno. 1 (2024)

引用0浏览0WOS引用

Patient Advocates and Researchers As Partners in Cancer Research: A Winning Combination

Laura D Porter,Karyn A Goodman,Josh Mailman, Wendy S Garrett

American Society of Clinical Oncology educational book American Society of Clinical Oncology Annual ...（2023）

引用2浏览0WOS引用

Genetic Profiling in the Randomized Controlled Phase 3 COMPOSE Trial of 177Lu-Edotreotide for Well-Differentiated Aggressive Grade 2/3 Gastroenteropancreatic Neuroendocrine Tumors

Thorvardur R. Halfdanarson,Jaume Capdevila, Daniel M. Halperin, Ken Herrmann,Grace Kong,Josh Mailman,Diane Reidy-Lagunes,Raj Srirajaskanthan,Cristina Sierras,Amanda Rotger

Endocrine Abstracts (2023)

引用0浏览0引用

Genetic Profiling Analysis Design of Well-Differentiated Aggressive Grade 2 and 3 Gastroenteropancreatic Neuroendocrine Tumors in the Phase III Randomized Controlled COMPOSE Trial

Thorvardur Ragnar Halfdanarson,Jaume Capdevila,Daniel M. Halperin,Ken Herrmann,Grace Kong,Simone Leyden,Josh Mailman,Diane Reidy-Lagunes,Rajaventhan Srirajaskanthan,Mate Erdo,Amanda Rotger,Thomas Thevenet

JOURNAL OF CLINICAL ONCOLOGY（2023）

引用0浏览0引用

Practical Considerations when Providing Palliative Care to Patients with Neuroendocrine Tumors in the Context of Routine Disease Management or Hospice Care

Jaydira Del Rivero,Josh Mailman,Michael W. Rabow,Jennifer A. Chan, Sarah Creed,Hagen F. Kennecke,Janice Pasieka, Jennifer Zuar,Simron Singh,Lauren Fishbein

Endocrine-Related Cancerno. 7 (2023)

引用2浏览0WOS引用

Consideration of Quality of Life in the Treatment Decision-Making for Patients with Advanced Gastroenteropancreatic Neuroendocrine Tumors

Boris G. Naraev,Josh Mailman,Thorvardur R. Halfdanarson,Heloisa P. Soares,Erik S. Mittra,Julie Hallet

EXPERT REVIEW OF ANTICANCER THERAPY（2023）

引用1浏览0WOS引用

Leadership in Patient Advocacy

Josh Mailman,Thomas A. Hope

Journal of Nuclear Medicineno. 4 (2022): 497-499

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn